APO Research
Talk to an analyst

APO RESEARCH · REPORT

Modified Proteomics Service

Compare research editions
View pricing & licenses

Selected research

Industry Research

Modified Proteomics Service Industry Research Report 2026

12 August 2026139 pages

Choose your research edition.

Industry ResearchModified Proteomics Service Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Modified Proteomics Service Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Modified Proteomics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Modified Proteomics Service Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Modified Proteomics Service Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Modified Proteomics Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Modified Proteomics Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Modified Proteomics Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Modified Proteomics Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Modified Proteomics Service include BGI Genomics, OmicScouts (Momentum Biotechnologies), Biodesix, Shanghai OE Biotech, Crown Bioscience, Shanghai Bioprofile, Creative Proteomics, Inotiv and MtoZ-Biolabs, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Modified Proteomics Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Modified Proteomics Service.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Modified Proteomics Service Market by Company

BGI Genomics

OmicScouts (Momentum Biotechnologies)

Biodesix

Shanghai OE Biotech

Crown Bioscience

Shanghai Bioprofile

Creative Proteomics

Inotiv

MtoZ-Biolabs

CellCarta

Biognosys

MS Bioworks

Charles River Laboratories

Metware Biotechnology

Novogene

Evotec

RxCelerate

Shanghai Majorbio Bio-Pharm

Lc-Bio Technologies

CD Genomics

Discovery Life Sciences

Applied Biomics

VProteomics

Allumiqs

Westlake Omics

CDI Labs

Proteome Sciences

Sapient Bioanalytics

Proteomics International

Cosmos Wisdom

MRM Proteomics

Sinotech Genomics

Precision Biomarker Laboratories (PBL)

PTM BIO

Cell Signaling Technology (CST)

APTBIO

Modified Proteomics Service Segment by Type

Phosphorylation

Acetylation

Ubiquitination

Methylation

Glycosylation

Lactylation

Redox

Palmitoylation

Others

Modified Proteomics Service Segment by Application

Clinical Diagnostics

Drug Discovery

Others

Modified Proteomics Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Modified Proteomics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Modified Proteomics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Modified Proteomics Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Modified Proteomics Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Modified Proteomics Service Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Modified Proteomics Service Revenue Market Share by Type (2021-2026) Table 7. Global Modified Proteomics Service Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Modified Proteomics Service Revenue Market Share by Type (2027-2032) Table 9. Global Modified Proteomics Service Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Modified Proteomics Service Revenue Market Share by Application (2021-2026) Table 11. Global Modified Proteomics Service Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Modified Proteomics Service Revenue Market Share by Application (2027-2032) Table 13. Global Modified Proteomics Service Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Modified Proteomics Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Modified Proteomics Service Market Share by Region (2021-2026) Table 16. Global Modified Proteomics Service Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Modified Proteomics Service Market Share by Region (2027-2032) Table 18. Modified Proteomics Service Industry Trends Table 19. Modified Proteomics Service Industry Drivers Table 20. Modified Proteomics Service Industry Opportunities and Challenges Table 21. Modified Proteomics Service Market Restraints Table 22. Global Top Modified Proteomics Service Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Modified Proteomics Service Revenue Market Share by Players (2021-2026) Table 24. Global Modified Proteomics Service Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Modified Proteomics Service, Headquarters and Area Served Table 26. Global Modified Proteomics Service Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Modified Proteomics Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Modified Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Modified Proteomics Service Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Modified Proteomics Service Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Modified Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Modified Proteomics Service Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Modified Proteomics Service Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Modified Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Modified Proteomics Service Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Modified Proteomics Service Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Modified Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Modified Proteomics Service Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Modified Proteomics Service Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Modified Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Modified Proteomics Service Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Modified Proteomics Service Market Size by Country (2027-2032) & (US$ Million) Table 45. BGI Genomics Company Information Table 46. BGI Genomics Business Overview Table 47. BGI Genomics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 48. BGI Genomics Modified Proteomics Service Product Portfolio Table 49. BGI Genomics Recent Developments Table 50. OmicScouts (Momentum Biotechnologies) Company Information Table 51. OmicScouts (Momentum Biotechnologies) Business Overview Table 52. OmicScouts (Momentum Biotechnologies) Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 53. OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Product Portfolio Table 54. OmicScouts (Momentum Biotechnologies) Recent Developments Table 55. Biodesix Company Information Table 56. Biodesix Business Overview Table 57. Biodesix Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 58. Biodesix Modified Proteomics Service Product Portfolio Table 59. Biodesix Recent Developments Table 60. Shanghai OE Biotech Company Information Table 61. Shanghai OE Biotech Business Overview Table 62. Shanghai OE Biotech Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 63. Shanghai OE Biotech Modified Proteomics Service Product Portfolio Table 64. Shanghai OE Biotech Recent Developments Table 65. Crown Bioscience Company Information Table 66. Crown Bioscience Business Overview Table 67. Crown Bioscience Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 68. Crown Bioscience Modified Proteomics Service Product Portfolio Table 69. Crown Bioscience Recent Developments Table 70. Shanghai Bioprofile Company Information Table 71. Shanghai Bioprofile Business Overview Table 72. Shanghai Bioprofile Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 73. Shanghai Bioprofile Modified Proteomics Service Product Portfolio Table 74. Shanghai Bioprofile Recent Developments Table 75. Creative Proteomics Company Information Table 76. Creative Proteomics Business Overview Table 77. Creative Proteomics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 78. Creative Proteomics Modified Proteomics Service Product Portfolio Table 79. Creative Proteomics Recent Developments Table 80. Inotiv Company Information Table 81. Inotiv Business Overview Table 82. Inotiv Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 83. Inotiv Modified Proteomics Service Product Portfolio Table 84. Inotiv Recent Developments Table 85. MtoZ-Biolabs Company Information Table 86. MtoZ-Biolabs Business Overview Table 87. MtoZ-Biolabs Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 88. MtoZ-Biolabs Modified Proteomics Service Product Portfolio Table 89. MtoZ-Biolabs Recent Developments Table 90. CellCarta Company Information Table 91. CellCarta Business Overview Table 92. CellCarta Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 93. CellCarta Modified Proteomics Service Product Portfolio Table 94. CellCarta Recent Developments Table 95. Biognosys Company Information Table 96. Biognosys Business Overview Table 97. Biognosys Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 98. Biognosys Modified Proteomics Service Product Portfolio Table 99. Biognosys Recent Developments Table 100. MS Bioworks Company Information Table 101. MS Bioworks Business Overview Table 102. MS Bioworks Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 103. MS Bioworks Modified Proteomics Service Product Portfolio Table 104. MS Bioworks Recent Developments Table 105. Charles River Laboratories Company Information Table 106. Charles River Laboratories Business Overview Table 107. Charles River Laboratories Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 108. Charles River Laboratories Modified Proteomics Service Product Portfolio Table 109. Charles River Laboratories Recent Developments Table 110. Metware Biotechnology Company Information Table 111. Metware Biotechnology Business Overview Table 112. Metware Biotechnology Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 113. Metware Biotechnology Modified Proteomics Service Product Portfolio Table 114. Metware Biotechnology Recent Developments Table 115. Novogene Company Information Table 116. Novogene Business Overview Table 117. Novogene Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 118. Novogene Modified Proteomics Service Product Portfolio Table 119. Novogene Recent Developments Table 120. Evotec Company Information Table 121. Evotec Business Overview Table 122. Evotec Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 123. Evotec Modified Proteomics Service Product Portfolio Table 124. Evotec Recent Developments Table 125. RxCelerate Company Information Table 126. RxCelerate Business Overview Table 127. RxCelerate Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 128. RxCelerate Modified Proteomics Service Product Portfolio Table 129. RxCelerate Recent Developments Table 130. Shanghai Majorbio Bio-Pharm Company Information Table 131. Shanghai Majorbio Bio-Pharm Business Overview Table 132. Shanghai Majorbio Bio-Pharm Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 133. Shanghai Majorbio Bio-Pharm Modified Proteomics Service Product Portfolio Table 134. Shanghai Majorbio Bio-Pharm Recent Developments Table 135. Lc-Bio Technologies Company Information Table 136. Lc-Bio Technologies Business Overview Table 137. Lc-Bio Technologies Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 138. Lc-Bio Technologies Modified Proteomics Service Product Portfolio Table 139. Lc-Bio Technologies Recent Developments Table 140. CD Genomics Company Information Table 141. CD Genomics Business Overview Table 142. CD Genomics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 143. CD Genomics Modified Proteomics Service Product Portfolio Table 144. CD Genomics Recent Developments Table 145. Discovery Life Sciences Company Information Table 146. Discovery Life Sciences Business Overview Table 147. Discovery Life Sciences Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 148. Discovery Life Sciences Modified Proteomics Service Product Portfolio Table 149. Discovery Life Sciences Recent Developments Table 150. Applied Biomics Company Information Table 151. Applied Biomics Business Overview Table 152. Applied Biomics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 153. Applied Biomics Modified Proteomics Service Product Portfolio Table 154. Applied Biomics Recent Developments Table 155. VProteomics Company Information Table 156. VProteomics Business Overview Table 157. VProteomics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 158. VProteomics Modified Proteomics Service Product Portfolio Table 159. VProteomics Recent Developments Table 160. Allumiqs Company Information Table 161. Allumiqs Business Overview Table 162. Allumiqs Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 163. Allumiqs Modified Proteomics Service Product Portfolio Table 164. Allumiqs Recent Developments Table 165. Westlake Omics Company Information Table 166. Westlake Omics Business Overview Table 167. Westlake Omics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 168. Westlake Omics Modified Proteomics Service Product Portfolio Table 169. Westlake Omics Recent Developments Table 170. CDI Labs Company Information Table 171. CDI Labs Business Overview Table 172. CDI Labs Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 173. CDI Labs Modified Proteomics Service Product Portfolio Table 174. CDI Labs Recent Developments Table 175. Proteome Sciences Company Information Table 176. Proteome Sciences Business Overview Table 177. Proteome Sciences Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 178. Proteome Sciences Modified Proteomics Service Product Portfolio Table 179. Proteome Sciences Recent Developments Table 180. Sapient Bioanalytics Company Information Table 181. Sapient Bioanalytics Business Overview Table 182. Sapient Bioanalytics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 183. Sapient Bioanalytics Modified Proteomics Service Product Portfolio Table 184. Sapient Bioanalytics Recent Developments Table 185. Proteomics International Company Information Table 186. Proteomics International Business Overview Table 187. Proteomics International Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 188. Proteomics International Modified Proteomics Service Product Portfolio Table 189. Proteomics International Recent Developments Table 190. Cosmos Wisdom Company Information Table 191. Cosmos Wisdom Business Overview Table 192. Cosmos Wisdom Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 193. Cosmos Wisdom Modified Proteomics Service Product Portfolio Table 194. Cosmos Wisdom Recent Developments Table 195. MRM Proteomics Company Information Table 196. MRM Proteomics Business Overview Table 197. MRM Proteomics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 198. MRM Proteomics Modified Proteomics Service Product Portfolio Table 199. MRM Proteomics Recent Developments Table 200. Sinotech Genomics Company Information Table 201. Sinotech Genomics Business Overview Table 202. Sinotech Genomics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 203. Sinotech Genomics Modified Proteomics Service Product Portfolio Table 204. Sinotech Genomics Recent Developments Table 205. Precision Biomarker Laboratories (PBL) Company Information Table 206. Precision Biomarker Laboratories (PBL) Business Overview Table 207. Precision Biomarker Laboratories (PBL) Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 208. Precision Biomarker Laboratories (PBL) Modified Proteomics Service Product Portfolio Table 209. Precision Biomarker Laboratories (PBL) Recent Developments Table 210. PTM BIO Company Information Table 211. PTM BIO Business Overview Table 212. PTM BIO Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 213. PTM BIO Modified Proteomics Service Product Portfolio Table 214. PTM BIO Recent Developments Table 215. Cell Signaling Technology (CST) Company Information Table 216. Cell Signaling Technology (CST) Business Overview Table 217. Cell Signaling Technology (CST) Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 218. Cell Signaling Technology (CST) Modified Proteomics Service Product Portfolio Table 219. Cell Signaling Technology (CST) Recent Developments Table 220. APTBIO Company Information Table 221. APTBIO Business Overview Table 222. APTBIO Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million) Table 223. APTBIO Modified Proteomics Service Product Portfolio Table 224. APTBIO Recent Developments Table 225. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Modified Proteomics Service Product Image Figure 5. Global Modified Proteomics Service Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Modified Proteomics Service Market Share by Type: 2025 VS 2032 Figure 7. Phosphorylation Product Figure 8. Acetylation Product Figure 9. Ubiquitination Product Figure 10. Methylation Product Figure 11. Glycosylation Product Figure 12. Lactylation Product Figure 13. Redox Product Figure 14. Palmitoylation Product Figure 15. Others Product Figure 16. Global Modified Proteomics Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Modified Proteomics Service Market Share by Application: 2025 VS 2032 Figure 18. Clinical Diagnostics Product Figure 19. Drug Discovery Product Figure 20. Others Product Figure 21. Global Modified Proteomics Service Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 22. Global Modified Proteomics Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 23. Global Modified Proteomics Service Market Share by Region: 2025 VS 2032 Figure 24. Global Modified Proteomics Service Market Share by Players in 2025 Figure 25. Global Modified Proteomics Service Manufacturers Established Date Figure 26. Global Top 5 and 10 Modified Proteomics Service Players Market Share by Revenue in 2025 Figure 27. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. North America Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. North America Modified Proteomics Service Market Share by Country (2021-2032) Figure 30. United States Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Canada Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Mexico Modified Proteomics Service Market Share by Country (2021-2032) Figure 33. Europe Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Modified Proteomics Service Market Share by Country (2021-2032) Figure 35. Germany Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. France Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. U.K. Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Italy Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Spain Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Russia Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Netherlands Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. Nordic Countries Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Asia-Pacific Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia-Pacific Modified Proteomics Service Market Share by Country (2021-2032) Figure 45. China Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. Japan Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South Korea Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. India Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. India Modified Proteomics Service Market Share by Country (2021-2032) Figure 50. Australia Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. China Taiwan Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Southeast Asia Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. South America Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. South America Modified Proteomics Service Market Share by Country (2021-2032) Figure 55. Brazil Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 56. Argentina Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 57. Chile Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 58. Colombia Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 59. Peru Modified Proteomics Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 60. BGI Genomics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 61. OmicScouts (Momentum Biotechnologies) Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 62. Biodesix Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 63. Shanghai OE Biotech Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 64. Crown Bioscience Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 65. Shanghai Bioprofile Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 66. Creative Proteomics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 67. Inotiv Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 68. MtoZ-Biolabs Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 69. CellCarta Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 70. Biognosys Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 71. MS Bioworks Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 72. Charles River Laboratories Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 73. Metware Biotechnology Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 74. Novogene Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 75. Evotec Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 76. RxCelerate Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 77. Shanghai Majorbio Bio-Pharm Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 78. Lc-Bio Technologies Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 79. CD Genomics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 80. Discovery Life Sciences Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 81. Applied Biomics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 82. VProteomics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 83. Allumiqs Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 84. Westlake Omics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 85. CDI Labs Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 86. Proteome Sciences Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 87. Sapient Bioanalytics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 88. Proteomics International Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 89. Cosmos Wisdom Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 90. MRM Proteomics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 91. Sinotech Genomics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 92. Precision Biomarker Laboratories (PBL) Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 93. PTM BIO Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 94. Cell Signaling Technology (CST) Revenue Growth Rate in Modified Proteomics Service Business (2021-2026) Figure 95. APTBIO Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Scope & coverage.

Types
  • Phosphorylation
  • Acetylation
  • Ubiquitination
  • Methylation
  • Glycosylation
  • Lactylation
  • Redox
  • Palmitoylation
  • Others
Applications
  • Clinical Diagnostics
  • Drug Discovery
  • Others
Companies covered
  • BGI Genomics
  • OmicScouts (Momentum Biotechnologies)
  • Biodesix
  • Shanghai OE Biotech
  • Crown Bioscience
  • Shanghai Bioprofile
  • Creative Proteomics
  • Inotiv
  • MtoZ-Biolabs
  • CellCarta
  • Biognosys
  • MS Bioworks
  • Charles River Laboratories
  • Metware Biotechnology
  • Novogene
  • Evotec
  • RxCelerate
  • Shanghai Majorbio Bio-Pharm
  • Lc-Bio Technologies
  • CD Genomics
  • Discovery Life Sciences
  • Applied Biomics
  • VProteomics
  • Allumiqs
  • Westlake Omics
  • CDI Labs
  • Proteome Sciences
  • Sapient Bioanalytics
  • Proteomics International
  • Cosmos Wisdom
  • MRM Proteomics
  • Sinotech Genomics
  • Precision Biomarker Laboratories (PBL)
  • PTM BIO
  • Cell Signaling Technology (CST)
  • APTBIO

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Modified Proteomics Service by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Phosphorylation
  5. 2.2.3 Acetylation
  6. 2.2.4 Ubiquitination
  7. 2.2.5 Methylation
  8. 2.2.6 Glycosylation
  9. 2.2.7 Lactylation
  10. 2.2.8 Redox
  11. 2.2.9 Palmitoylation
  12. 2.2.10 Others
  13. 2.3 Modified Proteomics Service by Application
  14. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.3.2 Clinical Diagnostics
  16. 2.3.3 Drug Discovery
  17. 2.3.4 Others
  18. 2.4 Assumptions and Limitations
3 Modified Proteomics Service Breakdown Data by Type
  1. 3.1 Global Modified Proteomics Service Historic Market Size by Type (2021-2026)
  2. 3.2 Global Modified Proteomics Service Forecasted Market Size by Type (2027-2032)
4 Modified Proteomics Service Breakdown Data by Application
  1. 4.1 Global Modified Proteomics Service Historic Market Size by Application (2021-2026)
  2. 4.2 Global Modified Proteomics Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Modified Proteomics Service Market Perspective (2021-2032)
  2. 5.2 Global Modified Proteomics Service Growth Trends by Region
  3. 5.2.1 Global Modified Proteomics Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Modified Proteomics Service Historic Market Size by Region (2021-2026)
  5. 5.2.3 Modified Proteomics Service Forecasted Market Size by Region (2027-2032)
  6. 5.3 Modified Proteomics Service Market Dynamics
  7. 5.3.1 Modified Proteomics Service Industry Trends
  8. 5.3.2 Modified Proteomics Service Market Drivers
  9. 5.3.3 Modified Proteomics Service Market Challenges
  10. 5.3.4 Modified Proteomics Service Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Modified Proteomics Service Players by Revenue
  2. 6.1.1 Global Top Modified Proteomics Service Players by Revenue (2021-2026)
  3. 6.1.2 Global Modified Proteomics Service Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Modified Proteomics Service Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Modified Proteomics Service Head Office and Area Served
  6. 6.4 Global Modified Proteomics Service Players, Product Type & Application
  7. 6.5 Global Modified Proteomics Service Manufacturers Established Date
  8. 6.6 Global Modified Proteomics Service Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Modified Proteomics Service Market Size (2021-2032)
  2. 7.2 North America Modified Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Modified Proteomics Service Market Size by Country (2021-2026)
  4. 7.4 North America Modified Proteomics Service Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Modified Proteomics Service Market Size (2021-2032)
  2. 8.2 Europe Modified Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Modified Proteomics Service Market Size by Country (2021-2026)
  4. 8.4 Europe Modified Proteomics Service Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Modified Proteomics Service Market Size (2021-2032)
  2. 9.2 Asia-Pacific Modified Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Modified Proteomics Service Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Modified Proteomics Service Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Modified Proteomics Service Market Size (2021-2032)
  2. 10.2 South America Modified Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Modified Proteomics Service Market Size by Country (2021-2026)
  4. 10.4 South America Modified Proteomics Service Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Modified Proteomics Service Market Size (2021-2032)
  2. 11.2 Middle East & Africa Modified Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Modified Proteomics Service Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Modified Proteomics Service Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 BGI Genomics
  2. 12.1.1 BGI Genomics Company Information
  3. 12.1.2 BGI Genomics Business Overview
  4. 12.1.3 BGI Genomics Revenue in Modified Proteomics Service Business (2021-2026)
  5. 12.1.4 BGI Genomics Modified Proteomics Service Product Portfolio
  6. 12.1.5 BGI Genomics Recent Developments
  7. 12.2 OmicScouts (Momentum Biotechnologies)
  8. 12.2.1 OmicScouts (Momentum Biotechnologies) Company Information
  9. 12.2.2 OmicScouts (Momentum Biotechnologies) Business Overview
  10. 12.2.3 OmicScouts (Momentum Biotechnologies) Revenue in Modified Proteomics Service Business (2021-2026)
  11. 12.2.4 OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Product Portfolio
  12. 12.2.5 OmicScouts (Momentum Biotechnologies) Recent Developments
  13. 12.3 Biodesix
  14. 12.3.1 Biodesix Company Information
  15. 12.3.2 Biodesix Business Overview
  16. 12.3.3 Biodesix Revenue in Modified Proteomics Service Business (2021-2026)
  17. 12.3.4 Biodesix Modified Proteomics Service Product Portfolio
  18. 12.3.5 Biodesix Recent Developments
  19. 12.4 Shanghai OE Biotech
  20. 12.4.1 Shanghai OE Biotech Company Information
  21. 12.4.2 Shanghai OE Biotech Business Overview
  22. 12.4.3 Shanghai OE Biotech Revenue in Modified Proteomics Service Business (2021-2026)
  23. 12.4.4 Shanghai OE Biotech Modified Proteomics Service Product Portfolio
  24. 12.4.5 Shanghai OE Biotech Recent Developments
  25. 12.5 Crown Bioscience
  26. 12.5.1 Crown Bioscience Company Information
  27. 12.5.2 Crown Bioscience Business Overview
  28. 12.5.3 Crown Bioscience Revenue in Modified Proteomics Service Business (2021-2026)
  29. 12.5.4 Crown Bioscience Modified Proteomics Service Product Portfolio
  30. 12.5.5 Crown Bioscience Recent Developments
  31. 12.6 Shanghai Bioprofile
  32. 12.6.1 Shanghai Bioprofile Company Information
  33. 12.6.2 Shanghai Bioprofile Business Overview
  34. 12.6.3 Shanghai Bioprofile Revenue in Modified Proteomics Service Business (2021-2026)
  35. 12.6.4 Shanghai Bioprofile Modified Proteomics Service Product Portfolio
  36. 12.6.5 Shanghai Bioprofile Recent Developments
  37. 12.7 Creative Proteomics
  38. 12.7.1 Creative Proteomics Company Information
  39. 12.7.2 Creative Proteomics Business Overview
  40. 12.7.3 Creative Proteomics Revenue in Modified Proteomics Service Business (2021-2026)
  41. 12.7.4 Creative Proteomics Modified Proteomics Service Product Portfolio
  42. 12.7.5 Creative Proteomics Recent Developments
  43. 12.8 Inotiv
  44. 12.8.1 Inotiv Company Information
  45. 12.8.2 Inotiv Business Overview
  46. 12.8.3 Inotiv Revenue in Modified Proteomics Service Business (2021-2026)
  47. 12.8.4 Inotiv Modified Proteomics Service Product Portfolio
  48. 12.8.5 Inotiv Recent Developments
  49. 12.9 MtoZ-Biolabs
  50. 12.9.1 MtoZ-Biolabs Company Information
  51. 12.9.2 MtoZ-Biolabs Business Overview
  52. 12.9.3 MtoZ-Biolabs Revenue in Modified Proteomics Service Business (2021-2026)
  53. 12.9.4 MtoZ-Biolabs Modified Proteomics Service Product Portfolio
  54. 12.9.5 MtoZ-Biolabs Recent Developments
  55. 12.10 CellCarta
  56. 12.10.1 CellCarta Company Information
  57. 12.10.2 CellCarta Business Overview
  58. 12.10.3 CellCarta Revenue in Modified Proteomics Service Business (2021-2026)
  59. 12.10.4 CellCarta Modified Proteomics Service Product Portfolio
  60. 12.10.5 CellCarta Recent Developments
  61. 12.11 Biognosys
  62. 12.11.1 Biognosys Company Information
  63. 12.11.2 Biognosys Business Overview
  64. 12.11.3 Biognosys Revenue in Modified Proteomics Service Business (2021-2026)
  65. 12.11.4 Biognosys Modified Proteomics Service Product Portfolio
  66. 12.11.5 Biognosys Recent Developments
  67. 12.12 MS Bioworks
  68. 12.12.1 MS Bioworks Company Information
  69. 12.12.2 MS Bioworks Business Overview
  70. 12.12.3 MS Bioworks Revenue in Modified Proteomics Service Business (2021-2026)
  71. 12.12.4 MS Bioworks Modified Proteomics Service Product Portfolio
  72. 12.12.5 MS Bioworks Recent Developments
  73. 12.13 Charles River Laboratories
  74. 12.13.1 Charles River Laboratories Company Information
  75. 12.13.2 Charles River Laboratories Business Overview
  76. 12.13.3 Charles River Laboratories Revenue in Modified Proteomics Service Business (2021-2026)
  77. 12.13.4 Charles River Laboratories Modified Proteomics Service Product Portfolio
  78. 12.13.5 Charles River Laboratories Recent Developments
  79. 12.14 Metware Biotechnology
  80. 12.14.1 Metware Biotechnology Company Information
  81. 12.14.2 Metware Biotechnology Business Overview
  82. 12.14.3 Metware Biotechnology Revenue in Modified Proteomics Service Business (2021-2026)
  83. 12.14.4 Metware Biotechnology Modified Proteomics Service Product Portfolio
  84. 12.14.5 Metware Biotechnology Recent Developments
  85. 12.15 Novogene
  86. 12.15.1 Novogene Company Information
  87. 12.15.2 Novogene Business Overview
  88. 12.15.3 Novogene Revenue in Modified Proteomics Service Business (2021-2026)
  89. 12.15.4 Novogene Modified Proteomics Service Product Portfolio
  90. 12.15.5 Novogene Recent Developments
  91. 12.16 Evotec
  92. 12.16.1 Evotec Company Information
  93. 12.16.2 Evotec Business Overview
  94. 12.16.3 Evotec Revenue in Modified Proteomics Service Business (2021-2026)
  95. 12.16.4 Evotec Modified Proteomics Service Product Portfolio
  96. 12.16.5 Evotec Recent Developments
  97. 12.17 RxCelerate
  98. 12.17.1 RxCelerate Company Information
  99. 12.17.2 RxCelerate Business Overview
  100. 12.17.3 RxCelerate Revenue in Modified Proteomics Service Business (2021-2026)
  101. 12.17.4 RxCelerate Modified Proteomics Service Product Portfolio
  102. 12.17.5 RxCelerate Recent Developments
  103. 12.18 Shanghai Majorbio Bio-Pharm
  104. 12.18.1 Shanghai Majorbio Bio-Pharm Company Information
  105. 12.18.2 Shanghai Majorbio Bio-Pharm Business Overview
  106. 12.18.3 Shanghai Majorbio Bio-Pharm Revenue in Modified Proteomics Service Business (2021-2026)
  107. 12.18.4 Shanghai Majorbio Bio-Pharm Modified Proteomics Service Product Portfolio
  108. 12.18.5 Shanghai Majorbio Bio-Pharm Recent Developments
  109. 12.19 Lc-Bio Technologies
  110. 12.19.1 Lc-Bio Technologies Company Information
  111. 12.19.2 Lc-Bio Technologies Business Overview
  112. 12.19.3 Lc-Bio Technologies Revenue in Modified Proteomics Service Business (2021-2026)
  113. 12.19.4 Lc-Bio Technologies Modified Proteomics Service Product Portfolio
  114. 12.19.5 Lc-Bio Technologies Recent Developments
  115. 12.20 CD Genomics
  116. 12.20.1 CD Genomics Company Information
  117. 12.20.2 CD Genomics Business Overview
  118. 12.20.3 CD Genomics Revenue in Modified Proteomics Service Business (2021-2026)
  119. 12.20.4 CD Genomics Modified Proteomics Service Product Portfolio
  120. 12.20.5 CD Genomics Recent Developments
  121. 12.21 Discovery Life Sciences
  122. 12.21.1 Discovery Life Sciences Company Information
  123. 12.21.2 Discovery Life Sciences Business Overview
  124. 12.21.3 Discovery Life Sciences Revenue in Modified Proteomics Service Business (2021-2026)
  125. 12.21.4 Discovery Life Sciences Modified Proteomics Service Product Portfolio
  126. 12.21.5 Discovery Life Sciences Recent Developments
  127. 12.22 Applied Biomics
  128. 12.22.1 Applied Biomics Company Information
  129. 12.22.2 Applied Biomics Business Overview
  130. 12.22.3 Applied Biomics Revenue in Modified Proteomics Service Business (2021-2026)
  131. 12.22.4 Applied Biomics Modified Proteomics Service Product Portfolio
  132. 12.22.5 Applied Biomics Recent Developments
  133. 12.23 VProteomics
  134. 12.23.1 VProteomics Company Information
  135. 12.23.2 VProteomics Business Overview
  136. 12.23.3 VProteomics Revenue in Modified Proteomics Service Business (2021-2026)
  137. 12.23.4 VProteomics Modified Proteomics Service Product Portfolio
  138. 12.23.5 VProteomics Recent Developments
  139. 12.24 Allumiqs
  140. 12.24.1 Allumiqs Company Information
  141. 12.24.2 Allumiqs Business Overview
  142. 12.24.3 Allumiqs Revenue in Modified Proteomics Service Business (2021-2026)
  143. 12.24.4 Allumiqs Modified Proteomics Service Product Portfolio
  144. 12.24.5 Allumiqs Recent Developments
  145. 12.25 Westlake Omics
  146. 12.25.1 Westlake Omics Company Information
  147. 12.25.2 Westlake Omics Business Overview
  148. 12.25.3 Westlake Omics Revenue in Modified Proteomics Service Business (2021-2026)
  149. 12.25.4 Westlake Omics Modified Proteomics Service Product Portfolio
  150. 12.25.5 Westlake Omics Recent Developments
  151. 12.26 CDI Labs
  152. 12.26.1 CDI Labs Company Information
  153. 12.26.2 CDI Labs Business Overview
  154. 12.26.3 CDI Labs Revenue in Modified Proteomics Service Business (2021-2026)
  155. 12.26.4 CDI Labs Modified Proteomics Service Product Portfolio
  156. 12.26.5 CDI Labs Recent Developments
  157. 12.27 Proteome Sciences
  158. 12.27.1 Proteome Sciences Company Information
  159. 12.27.2 Proteome Sciences Business Overview
  160. 12.27.3 Proteome Sciences Revenue in Modified Proteomics Service Business (2021-2026)
  161. 12.27.4 Proteome Sciences Modified Proteomics Service Product Portfolio
  162. 12.27.5 Proteome Sciences Recent Developments
  163. 12.28 Sapient Bioanalytics
  164. 12.28.1 Sapient Bioanalytics Company Information
  165. 12.28.2 Sapient Bioanalytics Business Overview
  166. 12.28.3 Sapient Bioanalytics Revenue in Modified Proteomics Service Business (2021-2026)
  167. 12.28.4 Sapient Bioanalytics Modified Proteomics Service Product Portfolio
  168. 12.28.5 Sapient Bioanalytics Recent Developments
  169. 12.29 Proteomics International
  170. 12.29.1 Proteomics International Company Information
  171. 12.29.2 Proteomics International Business Overview
  172. 12.29.3 Proteomics International Revenue in Modified Proteomics Service Business (2021-2026)
  173. 12.29.4 Proteomics International Modified Proteomics Service Product Portfolio
  174. 12.29.5 Proteomics International Recent Developments
  175. 12.30 Cosmos Wisdom
  176. 12.30.1 Cosmos Wisdom Company Information
  177. 12.30.2 Cosmos Wisdom Business Overview
  178. 12.30.3 Cosmos Wisdom Revenue in Modified Proteomics Service Business (2021-2026)
  179. 12.30.4 Cosmos Wisdom Modified Proteomics Service Product Portfolio
  180. 12.30.5 Cosmos Wisdom Recent Developments
  181. 12.31 MRM Proteomics
  182. 12.31.1 MRM Proteomics Company Information
  183. 12.31.2 MRM Proteomics Business Overview
  184. 12.31.3 MRM Proteomics Revenue in Modified Proteomics Service Business (2021-2026)
  185. 12.31.4 MRM Proteomics Modified Proteomics Service Product Portfolio
  186. 12.31.5 MRM Proteomics Recent Developments
  187. 12.32 Sinotech Genomics
  188. 12.32.1 Sinotech Genomics Company Information
  189. 12.32.2 Sinotech Genomics Business Overview
  190. 12.32.3 Sinotech Genomics Revenue in Modified Proteomics Service Business (2021-2026)
  191. 12.32.4 Sinotech Genomics Modified Proteomics Service Product Portfolio
  192. 12.32.5 Sinotech Genomics Recent Developments
  193. 12.33 Precision Biomarker Laboratories (PBL)
  194. 12.33.1 Precision Biomarker Laboratories (PBL) Company Information
  195. 12.33.2 Precision Biomarker Laboratories (PBL) Business Overview
  196. 12.33.3 Precision Biomarker Laboratories (PBL) Revenue in Modified Proteomics Service Business (2021-2026)
  197. 12.33.4 Precision Biomarker Laboratories (PBL) Modified Proteomics Service Product Portfolio
  198. 12.33.5 Precision Biomarker Laboratories (PBL) Recent Developments
  199. 12.34 PTM BIO
  200. 12.34.1 PTM BIO Company Information
  201. 12.34.2 PTM BIO Business Overview
  202. 12.34.3 PTM BIO Revenue in Modified Proteomics Service Business (2021-2026)
  203. 12.34.4 PTM BIO Modified Proteomics Service Product Portfolio
  204. 12.34.5 PTM BIO Recent Developments
  205. 12.35 Cell Signaling Technology (CST)
  206. 12.35.1 Cell Signaling Technology (CST) Company Information
  207. 12.35.2 Cell Signaling Technology (CST) Business Overview
  208. 12.35.3 Cell Signaling Technology (CST) Revenue in Modified Proteomics Service Business (2021-2026)
  209. 12.35.4 Cell Signaling Technology (CST) Modified Proteomics Service Product Portfolio
  210. 12.35.5 Cell Signaling Technology (CST) Recent Developments
  211. 12.36 APTBIO
  212. 12.36.1 APTBIO Company Information
  213. 12.36.2 APTBIO Business Overview
  214. 12.36.3 APTBIO Revenue in Modified Proteomics Service Business (2021-2026)
  215. 12.36.4 APTBIO Modified Proteomics Service Product Portfolio
  216. 12.36.5 APTBIO Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst